|
|
|
09 November 2023
Dr. Keith Smith, Healthcare Expert and Cofounder and Managing Partner of the Surgery Center of Oklahoma, discusses how Medicare's dual payment scheme jeopardizes patient health, how site-neutral reimbursement provides transparency and allows the free market to step in, and other insights and lessons learned when bureaucratic bloat is taken out of the equation.
0:00
0:00
Related Podcasts
04 November 2022
Timothy Lee, Senior Vice President of Legal and Public Affairs at the Center for Individual Freedom, discusses the U.S. Court of Appeals for the Fifth Circuit's recent decision ruling the Consumer Financial Protection Bureau's (CFPB) funding scheme to be unconstitutional, why the payday lending rule violates the Constitution's separation of powers, and how Congress created the agency that has too much unaccountable power.
08 March 2019
Christopher Horner, Senior Fellow at the Competitive Enterprise Institute, discusses environmental policy at the state level, the states' role in attorneys general-led climate crusades, and the Virginia legislature's efforts to thwart Michael Bloomberg's AG environmental attorney scheme.
28 April 2017
Catherine Engelbrecht, Founder of True the Vote, discusses a recent US District Court ruling that requires the IRS to turn over evidence of viewpoint based targeting, which singled out conservative and Tea Party groups for adverse treatment by the IRS.
22 September 2016
Dr. Scott Gottlieb, Resident Fellow at the American Enterprise Institute, discusses the history and regulations surrounding drug prices, who should finance important medical advancements, and the continuing Zika threat.
15 September 2016
Ken Girardin, Communications and Marketing Manager at the Empire Center for Public Policy, discusses New York Governor Cuomo's so-called Clean Energy Standard, how it will force electricity ratepayers to subsidize money-losing nuclear plants and costly windmills, solar panel farms, and why taxpayers outside of New York should be concerned as well.
12 August 2016
Dr. Scott Gottlieb, Resident Fellow at the American Enterprise Institute, discusses how to confront the growing risk from Zika, how the capacity to deal with such threats must be addressed and how FDA regulations present barriers to innovation.
